A study investigating CTNNB1, a gene encoding β-Catenin protein, which participates in the Wnt signaling pathway, in EOVC patients showed that the rate of mutation is higher compared with that in EEC patients, and is associated with excellent clinical outcomes (69). This evidence concerns the gene CTNNB1 and exstrophy-epispadias complex.